Company / Cash per Share
NewAmsterdam Pharma Co N.V. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.14
FY2025
5-year range
$4.14 / $8.18
FY2023-FY2025
Trend
-49.4%
vs FY2024
Sector context
#52 of 203
Health Care
What the data says
At $4.14, NewAmsterdam Pharma Co N.V.'s cash per share ranks #52 of 203 in the Health Care sector.
Based on SEC 10-K filings.
4.14 in FY2025.
Remained stable around $4.14 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#52 of 203 in Health CareTop 26% of 203This company $4.14 Sector average $76.43
▼
-94.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 49.4% year-over-year.
- Ranks #52 out of 203 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.14 | -49.4% |
| FY2024 | $8.18 | +97.4% |
| FY2023 | $4.14 | - |
| FY2022 | - | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026